Evofem Biosciences, Inc. EVFM
Set alert
0.01 USD 0.00 0.00%
At close · Oct 30
0.006 Day range 0.0063
0.001 52-week range 0.014
- YTD
- -40.00%
- 1 year
- -50.00%
- Open
- 0.0063
- Prev close
- 0.006
- Mkt cap
- 795.18K
- Vol
- 14.92K
- Avg vol
- 169.79K
- EPS
- -0.11
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.006
- High
- 0.0063
- Forward P/E
- -0.48
- Beta
- -1.68
- Short ratio
- 0.19
- Inst. own
- 9.67%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.74126
- 200-d avg
- 3.61
- 1y target
- 11.05
5Y chart
Events in this range
- May 6, 2022Split: 1 for 15
- May 10, 2022Rating: Morgan Stanley · — → Underweight
- May 11, 2022Rating: Morgan Stanley · — → Underweight
- May 25, 2022Rating: Piper Sandler · — → Overweight
- Jun 2, 2022Rating: Laidlaw & Co. · — → Buy
- Jul 15, 2022Rating: Morgan Stanley · — → Underweight
- Aug 15, 2022Rating: HC Wainwright & Co. · — → Buy
- May 18, 2023Split: 2 for 250
- Aug 14, 2023Earnings: -5.43; estimate 0; surprise —%
- Nov 14, 2023Earnings: 0.1; estimate 0; surprise —%
- Mar 27, 2024Earnings: -0.44; estimate 0; surprise —%
- May 15, 2024Earnings: -0.16; estimate 0; surprise —%
- Aug 14, 2024Earnings: 0; estimate 0; surprise —%
- Nov 14, 2024Earnings: -0.02; estimate 0; surprise —%
Signals (74)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 19, 2026 | 1 week ago |
| SMA: Bearish | Oct 12, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 12, 2026 | 2 weeks ago |
| SMA: Bullish | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Jul 13, 2026 | 3 months ago |
| SMA: Bullish | Jul 6, 2026 | 3 months ago |
| SMA: Bearish | Jun 22, 2026 | 4 months ago |
| SMA: Bullish | Jun 15, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 8, 2026 | 4 months ago |
| SMA: Bullish | Jun 1, 2026 | 5 months ago |
| SMA: Bearish | Apr 27, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 27, 2026 | 6 months ago |
| SMA: Bullish | Apr 6, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 6, 2026 | 6 months ago |
| SMA: Bearish | Mar 30, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 30, 2026 | 7 months ago |
| SMA: Bullish | Mar 23, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 23, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 16, 2026 | 7 months ago |
| MACD: Buy Signal | Feb 23, 2026 | 8 months ago |
| MACD: Sell Signal | Jan 19, 2026 | 9 months ago |
| SMA: Bearish | Dec 29, 2025 | 10 months ago |
| SMA: Bearish | Dec 29, 2025 | 10 months ago |
| SMA: Bullish | Dec 22, 2025 | 10 months ago |
| SMA: Bearish | Dec 15, 2025 | 10 months ago |
| SMA: Bullish | Dec 8, 2025 | 10 months ago |
| SMA: Bullish | Dec 8, 2025 | 10 months ago |
| SMA: Bearish | Nov 24, 2025 | 11 months ago |
| SMA: Bullish | Nov 17, 2025 | 11 months ago |
| SMA: Bearish | Oct 13, 2025 | 1 year ago |
| SMA: Bearish | Oct 13, 2025 | 1 year ago |
| SMA: Bullish | Aug 25, 2025 | 1 year ago |
| SMA: Bullish | Aug 25, 2025 | 1 year ago |
| SMA: Bearish | Aug 11, 2025 | 1 year ago |
| SMA: Bearish | Aug 11, 2025 | 1 year ago |
| SMA: Bullish | Aug 4, 2025 | 1 year ago |
| SMA: Bullish | Aug 4, 2025 | 1 year ago |
| SMA: Bearish | Jul 28, 2025 | 1 year ago |
| SMA: Bearish | Jul 28, 2025 | 1 year ago |
| SMA: Bullish | Jul 21, 2025 | 1 year ago |
| SMA: Bullish | Jul 21, 2025 | 1 year ago |
| SMA: Bearish | Jul 7, 2025 | 1 year ago |
| SMA: Bearish | Jul 7, 2025 | 1 year ago |
| SMA: Bullish | Jun 30, 2025 | 1 year ago |
| SMA: Bullish | Jun 30, 2025 | 1 year ago |
| SMA: Bearish | Jun 23, 2025 | 1 year ago |
| SMA: Bearish | Jun 23, 2025 | 1 year ago |
| SMA: Bullish | Jun 2, 2025 | 1 year ago |
| SMA: Bullish | Jun 2, 2025 | 1 year ago |
| SMA: Bearish | May 26, 2025 | 1 year ago |
| SMA: Bearish | May 26, 2025 | 1 year ago |
| SMA: Bullish | May 19, 2025 | 1 year ago |
| SMA: Bullish | May 19, 2025 | 1 year ago |
| SMA: Bearish | Apr 14, 2025 | 1 year ago |
| SMA: Bearish | Apr 14, 2025 | 1 year ago |
| RSI: Oversold | Apr 14, 2025 | 1 year ago |
| SMA: Bullish | Mar 17, 2025 | 1 year ago |
| SMA: Bullish | Mar 17, 2025 | 1 year ago |
| SMA: Bearish | Feb 3, 2025 | 1 year ago |
| SMA: Bullish | Jan 13, 2025 | 1 year ago |
| SMA: Bearish | Nov 11, 2024 | 1 year ago |
| SMA: Bearish | Nov 11, 2024 | 1 year ago |
| SMA: Bullish | Oct 28, 2024 | 2 years ago |
| SMA: Bullish | Oct 7, 2024 | 2 years ago |
| SMA: Bearish | Apr 24, 2023 | 3 years ago |
| SMA: Bullish | Apr 17, 2023 | 3 years ago |
| SMA: Bearish | Aug 8, 2022 | 4 years ago |
| RSI: Oversold | Aug 8, 2022 | 4 years ago |
| MACD: Buy Signal | Jul 11, 2022 | 4 years ago |
| RSI: Oversold | Jul 11, 2022 | 4 years ago |
| SMA: Bullish | Jun 27, 2022 | 4 years ago |
| RSI: Oversold | Mar 28, 2022 | 4 years ago |
| SMA: Bearish | Mar 7, 2022 | 4 years ago |
| SMA: Bullish | Jan 17, 2022 | 4 years ago |
Key statistics
- Market cap
- 27.34M
- Enterprise value
- 137.13M
- Trailing P/E
- 0.00
- Forward P/E
- -0.48
- PEG ratio
- 0.00
- Price / sales
- 1.76
- Price / book
- 0.00
- EPS (TTM)
- -19.01
- Beta
- -1.68
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 15.57M
- Revenue growth
- 224.90%
- Free cash flow
- 68.23M
- Total cash
- 19.89M
- Total debt
- 125.74M
- Return on equity
- 0.00%
- Shares outstanding
- 85.46M
- Short % of float
- 24.67%
- 50-day average
- 0.74126
- 200-day average
- 3.61
Analyst view
Consensus: buy
Buy
Price target (mean) 11.05 +184066.7% upside
Now 0.006
- Target (low)
- 0.75
- Target (mean)
- 11.05
- Target (high)
- 45.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.44.
Financials — quick view
EVFM Revenue — quarterly 5.81M
EVFM Net income — quarterly -2.35M
EVFM EPS — quarterly -1.85
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 14, 2024 | Sep 1, 2024 | 0.00 | -0.02 | — | — |
| Aug 14, 2024 | Jun 1, 2024 | 0.00 | 0.00 | — | — |
| May 15, 2024 | Mar 1, 2024 | 0.00 | -0.16 | — | — |
| Mar 27, 2024 | Dec 1, 2023 | 0.00 | -0.44 | — | — |
| Nov 14, 2023 | Sep 1, 2023 | 0.00 | 0.10 | — | — |
| Aug 14, 2023 | Jun 1, 2023 | 0.00 | -5.43 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 15, 2022 | HC Wainwright & Co. | main | — | Buy |
| Jul 15, 2022 | Morgan Stanley | main | — | Underweight |
| Jun 2, 2022 | Laidlaw & Co. | init | — | Buy |
| May 25, 2022 | Piper Sandler | main | — | Overweight |
| May 11, 2022 | Morgan Stanley | main | — | Underweight |
| May 10, 2022 | Morgan Stanley | main | — | Underweight |
About Evofem Biosciences, Inc.
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. Evofem Biosciences, Inc. is headquartered in San Diego, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- evofem.com
News
- Evofem Biosciences Adds Additional Manufacturing Capacity for PHEXX® to Support Global Growth Strategy
- HUB Cyber Security Expands Into Women's Health With Zero-Cash Acquisition of Evofem Notes, Advances Balance Sheet Turnaround
- Evofem Reports First Quarter 2026 Financial Results and Provides Business Update
- Evofem Announces Exclusive Agreement for the Distribution and Commercialization of SOLOSEC in Sub-Saharan Africa
- Head-To-Head Survey: Evofem Biosciences (NASDAQ:EVFM) and Ayala Pharmaceuticals (NASDAQ:ADXS)
- Evofem Reports Fifth Consecutive Year of Net Sales Growth
- Evofem CEO Saundra Pelletier Calls for a “Ground-Up Reset” of Women's Health at Fierce JPM Week 2026
- Evofem Expands “Say Vagina” Campaign With Launch of Say Vagina Store
- Financial Contrast: Evofem Biosciences (NASDAQ:EVFM) and BetterLife Pharma (OTCMKTS:PVOTF)
- Evofem Biosciences (NASDAQ:EVFM) Stock Passes Above 50 Day Moving Average – What’s Next?
Your note
Sign in to keep a note on EVFM — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BARRANS RUSSELL | Officer | Purchase | Jun 10, 2021 | 468,831 |
| CULWELL KELLY | Officer | Stock Award(Grant) | Feb 2, 2021 | 315,451 |
| FILE JUSTIN J | Chief Financial Officer | Stock Award(Grant) | Feb 17, 2022 | 810,982 |
| FITZPATRICK ALEXANDER A. | General Counsel | Stock Award(Grant) | Feb 17, 2022 | 516,422 |
| HALL WILLIAM WALMSLEY | Director | Purchase | Jun 14, 2020 | 5,000 |
| INVESCO, LTD. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Jun 4, 2020 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Baker Brothers Advisors, LLC | 3.13% | 2,583,616 | 826.50K | Jun 29, 2022 |
| Alyeska Investment Group, L.p. | 2.37% | 1,950,607 | 624.00K | Jun 29, 2022 |
| Vanguard Group, Inc. (The) | 1.58% | 1,304,514 | 417.31K | Jun 29, 2022 |
| Citigroup Inc. | 0.89% | 736,406 | 235.58K | Jun 29, 2022 |
| Blackrock Inc. | 0.28% | 234,225 | 74.93K | Jun 29, 2022 |
| Citadel Advisors Llc | 0.25% | 210,122 | 67.22K | Jun 29, 2022 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 0.14% | 260,679 | 83.39K | Mar 30, 2022 |
| Vanguard Extended Market Index Fund | 0.08% | 154,404 | 49.39K | Mar 30, 2022 |
| Fidelity Extended Market Index Fund | 0.07% | 59,265 | 18.96K | Jun 29, 2022 |
| Fidelity Total Market Index Fund | 0.02% | 14,358 | 4.59K | Jun 29, 2022 |
| Vanguard Institutional Index-Inst Total Stock Market Ind | 0.01% | 8,791 | 2.81K | Jun 29, 2022 |
| Fidelity Series Total Market Index Fund | 0.01% | 8,831 | 2.83K | Jun 29, 2022 |